Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 3 | 2009 | 207 | 0.530 |
Why?
|
| Brain Mapping | 3 | 2009 | 37 | 0.530 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 17 | 0.370 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 24 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 39 | 0.300 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 1 | 0.290 |
Why?
|
| Motor Cortex | 1 | 2009 | 3 | 0.290 |
Why?
|
| Auditory Cortex | 1 | 2005 | 1 | 0.230 |
Why?
|
| Language | 1 | 2005 | 15 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 36 | 0.230 |
Why?
|
| Adult | 9 | 2021 | 1670 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 8 | 0.190 |
Why?
|
| Humans | 14 | 2021 | 5837 | 0.190 |
Why?
|
| Patient Care Planning | 1 | 2001 | 4 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 11 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 21 | 0.170 |
Why?
|
| Radiology | 1 | 2021 | 5 | 0.170 |
Why?
|
| Encephalocele | 1 | 2021 | 4 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 35 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 26 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2021 | 27 | 0.160 |
Why?
|
| Female | 8 | 2021 | 3346 | 0.150 |
Why?
|
| Male | 10 | 2009 | 3399 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 19 | 0.110 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 5 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 125 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2003 | 46 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2003 | 45 | 0.090 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 7 | 0.080 |
Why?
|
| Contrast Media | 1 | 2010 | 16 | 0.080 |
Why?
|
| Middle Aged | 6 | 2008 | 1775 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 45 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 94 | 0.070 |
Why?
|
| Subclavian Artery | 1 | 2008 | 1 | 0.070 |
Why?
|
| Vertebral Artery | 1 | 2008 | 1 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 163 | 0.070 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 2 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 3 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 3 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 6 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 150 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2021 | 584 | 0.050 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 2 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 2 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 4 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 6 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 3 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 17 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 13 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 17 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 411 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 1 | 0.040 |
Why?
|
| Renal Artery | 1 | 2001 | 2 | 0.040 |
Why?
|
| Pelvis | 1 | 2001 | 9 | 0.040 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.040 |
Why?
|
| Petrous Bone | 1 | 2021 | 3 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 27 | 0.040 |
Why?
|
| Child | 1 | 2021 | 339 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 13 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 1 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 1999 | 7 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 1 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 5 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 12 | 0.040 |
Why?
|
| Brain | 1 | 2021 | 331 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 4 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 3 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 3 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 1995 | 24 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 1 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 8 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 1 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 2 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 4 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 174 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 8 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 72 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 42 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 62 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 203 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 90 | 0.010 |
Why?
|
| Aged | 2 | 1995 | 1860 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 4 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 5 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 8 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 15 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 1 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 37 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 3 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 13 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 30 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 15 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 87 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 282 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 2 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 6 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 14 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 1349 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 118 | 0.010 |
Why?
|
| Acute Disease | 1 | 1994 | 47 | 0.010 |
Why?
|
| Adolescent | 1 | 1995 | 488 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 333 | 0.010 |
Why?
|